Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 44.23 | N/A |
| PEG Ratio (TTM) | -0.72 | N/A |
| P/S Ratio (TTM) | 1.45 | N/A |
| P/B Ratio (TTM) | 1.00 | N/A |
| P/FCF Ratio (TTM) | 7.64 | N/A |
| Price to 5YR AVG Earnings Ratio | 46.51 | N/A |
| Price to 5YR AVG FCF Ratio | 7.43 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.76% | N/A |
| ROE (TTM) | 2.23% | N/A |
| Net Profit Margin (TTM) | 2.87% | N/A |
| ROIC 5YR AVG | 4.63% | N/A |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -36.49% | -42.47% | 5.68% |
| Revenue | 2.08% | -13.87% | -3.38% |
| Net Income | -38.39% | -40.05% | 12.17% |
| Cash Flow | 149.51% | 56.74% | 47.11% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.24 | N/A |
| Quick Ratio (TTM) | 4.28 | N/A |
| D/E Ratio (TTM) | 0.01 | N/A |
| Interest Coverage (TTM) | 10.90 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 3.76 | N/A |
| LTL to 5YR AVG FCF | 0.18 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.95% | N/A |